Patient Death in China Gene Editing Trial Draws Fire: Journal The death of a six year old girl in a gene editing trial at Shanghai Xinhua Hospital has sparked widespread concern over regulatory oversight, transparency, and the ethics surrounding gene editing experiments.
The case is a stark reminder of the risks associated with China's rapid expansion into biotechnology.
China's investigator initiated trials (IITs) have surged in recent years, growing 11 fold from 2015 to 2023 to top 1,000.